Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.The staff at Alkermes come from unusually diverse demographic backgrounds. The company is 37.4% female and 33.5% ethnic minorities. Alkermes employees are slightly more likely to be members of the Democratic Party than the Republican Party, with 61.0% of employees identifying as members of the Democratic Party. Despite their political differences, employees at Alkermes seem to be happy. The company has great employee retention with staff members usually staying for 3.8 years.The average employee at Alkermes makes $76,854 per year. In comparison, some of its highest paying competitors, like Sanofi Genzyme, Amyris, and ImClone Systems LLC, pay $84,495, $82,561, and $81,730, respectively.A large health care company with 1,200 employees and an annual revenue of $1.0B, Alkermes is headquartered in Waltham, MA.
Alkermes's Mission Statement
Alkermes applies our scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
The founders of Alkermes are Floyd Bloom, John Clarke, Michael Wall and Paul Schimmel.
The key people at Alkermes are Richard F. Pops, Floyd Bloom and John Clarke.
Key People
Richard F. Pops
Floyd Bloom
John Clarke
Michael Wall
Paul Schimmel
Alkermes Rankings
Alkermes is ranked #29 on the Best Health Care Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
The average an Alkermes salary in the United States is $76,854 per year.
Alkermes employees in the top 10 percent can make over $129,000 per year,
while Alkermes employees at the bottom 10 percent earn less than $45,000 per year.
Average Alkermes Salary
$76,854
yearly
$36.95 hourly
Updated March 14, 2024
Rate Alkermes' commitment to diversity and inclusion.
Alkermes diversity
9.6
Diversity Score
We calculated Alkermes’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Alkermes’s workforce.
Alkermes diversity summary. Zippia estimates Alkermes's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Alkermes's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Alkermes's workforce.
Alkermes has 1,200 employees.
37% of Alkermes employees are women, while 63% are men.
The most common ethnicity at Alkermes is White (67%).
10% of Alkermes employees are Hispanic or Latino.
10% of Alkermes employees are Asian.
The average employee at Alkermes makes $76,854 per year.
Alkermes employees are most likely to be members of the democratic party.
Employees at Alkermes stay with the company for 3.8 years on average.
Do you work at Alkermes?
Were you satisfied with Alkermes' salary and benefits?
Alkermes Financial Performance
10.0
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Alkermes currently has 1.1B in revenue. Alkermes's most recent quarter produced 380.9m (q3'2023).
Alkermes annual revenue
$1B
$939M
$704M
$470M
$235M
$0
2017
2018
2019
2020
2021
2022
Highest paying Alkermes competitors
Compare Alkermes salaries to competitors, including Sanofi Genzyme, Amyris, and ImClone Systems LLC. Employees at Sanofi Genzyme earn the highest average yearly salary of $84,495. The salaries at Amyris average $82,561 per year, and the salaries at ImClone Systems LLC come in at $81,730 per year.
Zippia gives an in-depth look into the details of Alkermes, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alkermes. The employee data is based on information from people who have self-reported their past or current employments at Alkermes. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alkermes. The data presented on this page does not represent the view of Alkermes and its employees or that of Zippia.
Alkermes may also be known as or be related to ALKERMES INC, Alkermes, Alkermes Controlled Therapeutics Inc, Alkermes Inc and Alkermes plc.